Logo

PanTherix, Genome Therapeutics Collaborate on Protein Structure Analysis for Drug Targets

Jan 23, 2003

NEW YORK, Jan. 23 - PanTherix and Genome Therapeutics said today they have entered a research collaboration in the search for drug targets.

 

Genome Therapeutics will use PanTherix's protein structure determination technology to unlock the three-dimensional structures of its bacterial targets in its anti-infective drug discovery program, the company said.

 

Financial terms of the agreement were not disclosed.

 

Click here for more information.

 

 

Breaking News
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.